Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity

Cell Stem Cell

Volumn 11, Issue 6, 2012, Pages 825-835

  Lee, Ryang Hwa ^a   Yoon, Nara ^a   Reneau, John C ^a   Prockop, Darwin J ^a  

^a Texas Agricultural and Mechanical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN D3; DOXORUBICIN; PROTEIN P21; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL ACTIVATION; CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG TUMOR; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; UPREGULATION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; DOXORUBICIN; HUMANS; INFUSIONS, INTRAVENOUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84870929405     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2012.10.001     Document Type: Article

References (62)

1. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738
2. N. Arbour, E. Rastikerdar, E. McCrea, Y. Lapierre, J. Dörr, A. Bar-Or, and J.P. Antel Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate Mult. Scler. 11 2005 652 657
3. A. Bafico, G. Liu, L. Goldin, V. Harris, and S.A. Aaronson An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells Cancer Cell 6 2004 497 506
4. E.C. Borden, B. Jacobs, E. Hollovary, L. Rybicki, P. Elson, T. Olencki, and P. Triozzi Gene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trial J. Interferon Cytokine Res. 31 2011 433 440
5. D.J. Buchsbaum, T. Zhou, W.E. Grizzle, P.G. Oliver, C.J. Hammond, S. Zhang, M. Carpenter, and A.F. LoBuglio Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model Clin. Cancer Res. 9 2003 3731 3741
6. M.D. Castellone, H. Teramoto, B.O. Williams, K.M. Druey, and J.S. Gutkind Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 2005 1504 1510
7. G.Y. Chen, and G. Nuñez Sterile inflammation: sensing and reacting to damage Nat. Rev. Immunol. 10 2010 826 837
8. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
9. A. Devitt, S. Pierce, C. Oldreive, W.H. Shingler, and C.D. Gregory CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine Cell Death Differ. 10 2003 371 382
10. C.M. Digirolamo, D. Stokes, D. Colter, D.G. Phinney, R. Class, and D.J. Prockop Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate Br. J. Haematol. 107 1999 275 281
11. F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noël, and C. Jorgensen Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals Blood 102 2003 3837 3844
12. F. Djouad, C. Bony, F. Apparailly, P. Louis-Plence, C. Jorgensen, and D. Noël Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells Transplantation 82 2006 1060 1066
13. Y. Gazitt TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells Leukemia 13 1999 1817 1824
14. J.M. González-Sancho, O. Aguilera, J.M. García, N. Pendás-Franco, C. Peña, S. Cal, A. García de Herreros, F. Bonilla, and A. Muñoz The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer Oncogene 24 2005 1098 1103
15. G. Grisendi, R. Bussolari, L. Cafarelli, I. Petak, V. Rasini, E. Veronesi, G. De Santis, C. Spano, M. Tagliazzucchi, and H. Barti-Juhasz Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy Cancer Res. 70 2010 3718 3729
16. N. Ida, N. Uenishi, A. Kajita, and Y. Satoh Antitumor effect of human fibroblast interferon on the growth of human melanoma cells implanted in nude mice Gann 73 1982 952 960
17. R.W. Johnstone, A.J. Frew, and M.J. Smyth The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat. Rev. Cancer 8 2008 782 798
18. M. Kanehira, H. Xin, K. Hoshino, M. Maemondo, H. Mizuguchi, T. Hayakawa, K. Matsumoto, T. Nakamura, T. Nukiwa, and Y. Saijo Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells Cancer Gene Ther. 14 2007 894 903
19. K. Karikó, H. Ni, J. Capodici, M. Lamphier, and D. Weissman mRNA is an endogenous ligand for Toll-like receptor 3 J. Biol. Chem. 279 2004 12542 12550
20. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, and R.A. Weinberg Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 2007 557 563
21. M.M. Keane, S.A. Ettenberg, M.M. Nau, E.K. Russell, and S. Lipkowitz Chemotherapy augments TRAIL-induced apoptosis in breast cell lines Cancer Res. 59 1999 734 741
22. S.K. Kelley, L.A. Harris, D. Xie, L. Deforge, K. Totpal, J. Bussiere, and J.A. Fox Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety J. Pharmacol. Exp. Ther. 299 2001 31 38
23. S. Kidd, L. Caldwell, M. Dietrich, I. Samudio, E.L. Spaeth, K. Watson, Y. Shi, J. Abbruzzese, M. Konopleva, M. Andreeff, and F.C. Marini Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment Cytotherapy 12 2010 615 625
24. A.H. Klopp, E.L. Spaeth, J.L. Dembinski, W.A. Woodward, A. Munshi, R.E. Meyn, J.D. Cox, M. Andreeff, and F.C. Marini Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment Cancer Res. 67 2007 11687 11695
25. U. Krause, S. Harris, A. Green, J. Ylostalo, S. Zeitouni, N. Lee, and C.A. Gregory Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy Proc. Natl. Acad. Sci. USA 107 2010 4147 4152
26. L. Kucerova, V. Altanerova, M. Matuskova, S. Tyciakova, and C. Altaner Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy Cancer Res. 67 2007 6304 6313
27. S. Kuphal, S. Lodermeyer, F. Bataille, M. Schuierer, B.H. Hoang, and A.K. Bosserhoff Expression of Dickkopf genes is strongly reduced in malignant melanoma Oncogene 25 2006 5027 5036
28. A.V. Kurtova, K. Balakrishnan, R. Chen, W. Ding, S. Schnabl, M.P. Quiroga, M. Sivina, W.G. Wierda, Z. Estrov, and M.J. Keating Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance Blood 114 2009 4441 4450
29. B.L. Larson, J. Ylostalo, R.H. Lee, C. Gregory, and D.J. Prockop Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells Tissue Eng. Part A 16 2010 3385 3394
30. E.J. Lee, M. Jo, S.B. Rho, K. Park, Y.N. Yoo, J. Park, M. Chae, W. Zhang, and J.H. Lee Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin Int. J. Cancer 124 2009 287 297
31. R.H. Lee, A.A. Pulin, M.J. Seo, D.J. Kota, J. Ylostalo, B.L. Larson, L. Semprun-Prieto, P. Delafontaine, and D.J. Prockop Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 Cell Stem Cell 5 2009 54 63
32. M. Lepourcelet, Y.N. Chen, D.S. France, H. Wang, P. Crews, F. Petersen, C. Bruseo, A.W. Wood, and R.A. Shivdasani Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex Cancer Cell 5 2004 91 102
33. X. Ling, F. Marini, M. Konopleva, W. Schober, Y. Shi, J. Burks, K. Clise-Dwyer, R.Y. Wang, W. Zhang, and X. Yuan Mesenchymal stem cells overexpressing IFN-beta inhibit breast cancer growth and metastases through Stat3 signaling in a syngeneic tumor model Cancer Microenviron 3 2010 83 95
34. M.R. Loebinger, A. Eddaoudi, D. Davies, and S.M. Janes Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer Cancer Res. 69 2009 4134 4142
35. J. Luo, N.L. Solimini, and S.J. Elledge Principles of cancer therapy: oncogene and non-oncogene addiction Cell 136 2009 823 837
36. J.C. Mallory, G. Crudden, A. Oliva, C. Saunders, A. Stromberg, and R.J. Craven A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells Mol. Pharmacol. 68 2005 1747 1756
37. L.G. Menon, K. Kelly, H.W. Yang, S.K. Kim, P.M. Black, and R.S. Carroll Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy Stem Cells 27 2009 2320 2330
38. A. Mohr, M. Lyons, L. Deedigan, T. Harte, G. Shaw, L. Howard, F. Barry, T. O'Brien, and R. Zwacka Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model J. Cell. Mol. Med. 12 6B 2008 2628 2643
39. L.P. Mueller, J. Luetzkendorf, M. Widder, K. Nerger, H. Caysa, and T. Mueller TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo Cancer Gene Ther. 18 2011 229 239
40. S.A. Patel, J.R. Meyer, S.J. Greco, K.E. Corcoran, M. Bryan, and P. Rameshwar Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta J. Immunol. 184 2010 5885 5894
41. D.G. Phinney, G. Kopen, W. Righter, S. Webster, N. Tremain, and D.J. Prockop Donor variation in the growth properties and osteogenic potential of human marrow stromal cells J. Cell. Biochem. 75 1999 424 436
42. D.J. Prockop, D.J. Kota, N. Bazhanov, and R.L. Reger Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs) J. Cell. Mol. Med. 14 2010 2190 2199
43. M. Rahman, S.R. Davis, J.G. Pumphrey, J. Bao, M.M. Nau, P.S. Meltzer, and S. Lipkowitz TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype Breast Cancer Res. Treat. 113 2009 217 230
44. C.F. Reich 3rd, and D.S. Pisetsky The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis Exp. Cell Res. 315 2009 760 768
45. I. Rivera-Walsh, M. Waterfield, G. Xiao, A. Fong, and S.C. Sun NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death J. Biol. Chem. 276 2001 40385 40388
46. V. Rus, V. Zernetkina, R. Puliaev, C. Cudrici, S. Mathai, and C.S. Via Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease Clin. Immunol. 117 2005 48 56
47. I. Sekiya, B.L. Larson, J.R. Smith, R. Pochampally, J.G. Cui, and D.J. Prockop Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality Stem Cells 20 2002 530 541
48. J. Shao, C. Jung, C. Liu, and H. Sheng Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer J. Biol. Chem. 280 2005 26565 26572
49. T.R. Singh, S. Shankar, X. Chen, M. Asim, and R.K. Srivastava Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo Cancer Res. 63 2003 5390 5400
50. M. Studeny, F.C. Marini, J.L. Dembinski, C. Zompetta, M. Cabreira-Hansen, B.N. Bekele, R.E. Champlin, and M. Andreeff Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents J. Natl. Cancer Inst. 96 2004 1593 1603
51. H. Suzuki, D.N. Watkins, K.W. Jair, K.E. Schuebel, S.D. Markowitz, W.D. Chen, T.P. Pretlow, B. Yang, Y. Akiyama, and M. Van Engeland Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat. Genet. 36 2004 417 422
52. C. Tecchio, V. Huber, P. Scapini, F. Calzetti, D. Margotto, G. Todeschini, L. Pilla, G. Martinelli, G. Pizzolo, L. Rivoltini, and M.A. Cassatella IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells Blood 103 2004 3837 3844
53. O. Tetsu, and F. McCormick Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature 398 1999 422 426
54. K. Tian, S. Yang, Q. Ren, Z. Han, S. Lu, F. Ma, L. Zhang, and Z. Han p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells Cell. Physiol. Biochem. 26 2010 799 808
55. J. Veeck, and E. Dahl Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3 Biochim. Biophys. Acta 1825 2012 18 28
56. J. Veeck, N. Bektas, A. Hartmann, G. Kristiansen, U. Heindrichs, R. Knüchel, and E. Dahl Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours Breast Cancer Res. 10 2008 R82
57. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat. Med. 10 2004 789 799
58. M. Wolfe, R. Pochampally, W. Swaney, and R.L. Reger Isolation and culture of bone marrow-derived human multipotent stromal cells (hMSCs) Methods Mol. Biol. 449 2008 3 25
59. H. Xin, M. Kanehira, H. Mizuguchi, T. Hayakawa, T. Kikuchi, T. Nukiwa, and Y. Saijo Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells Stem Cells 25 2007 1618 1626
60. W. Yue, Q. Sun, S. Dacic, R.J. Landreneau, J.M. Siegfried, J. Yu, and L. Zhang Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer Carcinogenesis 29 2008 84 92
61. Q. Zhang, M. Raoof, Y. Chen, Y. Sumi, T. Sursal, W. Junger, K. Brohi, K. Itagaki, and C.J. Hauser Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 464 2010 104 107
62. Y. Zhu, Z. Sun, Q. Han, L. Liao, J. Wang, C. Bian, J. Li, X. Yan, Y. Liu, C. Shao, and R.C. Zhao Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1 Leukemia 23 2009 925 933